84 related articles for article (PubMed ID: 1002987)
1. Investigations of the complement-fixing sites of immunoglobulins.
Johnson BJ; Thames KE
J Immunol; 1976 Nov; 117(5 Pt 1):1491-4. PubMed ID: 1002987
[TBL] [Abstract][Full Text] [Related]
2. Complement fixing site of human IgG1.
Johnson BJ; Thames KE
J Pharm Sci; 1977 Mar; 66(3):427-8. PubMed ID: 845812
[TBL] [Abstract][Full Text] [Related]
3. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
4. The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities. II. Structural requirements of the immunoglobulin.
Pfueller SL; Lüscher EF
J Immunol; 1972 Sep; 109(3):526-33. PubMed ID: 4341271
[No Abstract] [Full Text] [Related]
5. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens.
Bartel G; Wahrmann M; Exner M; Regele H; Schillinger M; Hörl WH; Böhmig GA
Transplantation; 2007 Mar; 83(6):727-33. PubMed ID: 17414705
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
Ebanks RO; Isenman DE
J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of human immunoglobulins.
Maddison SE
Health Lab Sci; 1972 Jul; 9(3):167-77. PubMed ID: 4114673
[No Abstract] [Full Text] [Related]
8. Binding of synthetic peptides by a human monoclonal IgM with an unusual combining site structure.
Edmundson AB; Tribbick G; Plompen S; Geysen HM; Yuriev E; Ramsland PA
J Mol Recognit; 2001; 14(4):229-38. PubMed ID: 11500969
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of the binding and activation of the first component of human complement. The effect of synthetic peptides, immunoglobulin fragments and various proteins].
Kozlov LV; Sizoĭ MN; Zinchenko AA; Levkovskiĭ AV
Biokhimiia; 1986 May; 51(5):707-18. PubMed ID: 3486677
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.
Lukas TJ; Muñoz H; Erickson BW
J Immunol; 1981 Dec; 127(6):2555-60. PubMed ID: 7299136
[TBL] [Abstract][Full Text] [Related]
11. Replacement of lysine by arginine, phenylalanine, and tryptophan in the reactive site of the trypsin-kallikrein inhibitor (Kunitz).
Jering H; Tschesche H
Angew Chem Int Ed Engl; 1974 Oct; 13(10):662-3. PubMed ID: 4215343
[No Abstract] [Full Text] [Related]
12. [Synthesis of immunopoietins--new biologically active low molecular weight fragments of immunoglobulins G, M, E and A].
Chipens GI; Antsans IuE; Zarin'sh PP; Osis LP
Bioorg Khim; 1985 Apr; 11(4):437-46. PubMed ID: 4004957
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
[TBL] [Abstract][Full Text] [Related]
14. The structure of immunoglobulins.
Porter RR
Essays Biochem; 1967; 3():1-24. PubMed ID: 4183289
[No Abstract] [Full Text] [Related]
15. [Various research results on the role of carbohydrate groups in macroimmunoglobulins].
Kaverzneva ED
Biokhimiia; 1989 Apr; 54(4):580-6. PubMed ID: 2758069
[TBL] [Abstract][Full Text] [Related]
16. The response to Trypanosoma congolense infection in calves. Determination of immunoglobulins igG1, igG2, igM and C3 levels and the complement fixing antibody titres during the course of infection.
Kobayashi A; Tizard IR
Tropenmed Parasitol; 1976 Dec; 27(4):411-7. PubMed ID: 1006799
[TBL] [Abstract][Full Text] [Related]
17. The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities. I. Studies of immunoglobulins of different types.
Pfueller SL; Lüscher EF
J Immunol; 1972 Sep; 109(3):517-25. PubMed ID: 5066345
[No Abstract] [Full Text] [Related]
18. The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.
Isenman DE; Dorrington KJ; Painter RH
J Immunol; 1975 Jun; 114(6):1726-9. PubMed ID: 1127227
[TBL] [Abstract][Full Text] [Related]
19. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
[TBL] [Abstract][Full Text] [Related]
20. Non-complement-fixing IgM antibodies in the guinea pig.
Linscott WD; Hansen SS
J Immunol; 1969 Sep; 103(3):423-8. PubMed ID: 5805428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
